H2AX and myelodysplastic syndrome: Loss of H2AX induced dyserythropoiesis mainly in late-stage terminal erythroblasts, consistent with the observation that dysplastic erythroid cells are mostly in polychromatic and orthochromatic stages in MDS patients.